Update shared on 03 Dec 2025
Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts.
Valuation Changes
- Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.
- Discount Rate risen very slightly from about 6.85 percent to 6.85 percent, reflecting a marginally higher required rate of return.
- Revenue Growth effectively unchanged at around 9.83 percent, suggesting a stable outlook for top line expansion.
- Net Profit Margin fallen slightly from roughly 7.21 percent to 7.19 percent, indicating a modestly lower profitability assumption.
- Future P/E risen slightly from about 12.41x to 12.44x, implying a marginally higher valuation multiple applied to forward earnings.
Have other thoughts on AXA?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.